Recent Trends in Cardiovascular Disease Mortality in Kazakhstan

Figures & data

Figure 1 Age-adjusted avoidable, treatable and preventable mortality rate from cardiovascular disease.

Table 1 Number and Rate of Avoidable Mortality from Cardiovascular Disease (100,000 Population), by Age and Sex in Kazakhstan from 2011 to 2021

		2011		2021			Average Annual Percentage Change (95% CI)*
		No	Rate (95% CI)	No	Rate (95% CI)	Rate Ratio	2011–2021	2011–2015	2016–2021
Sex	Males	15,614	389.6 (383.0 to 396.2)	12,604	243.7 (239.2 to 248.1)	2.2	−4.2 (−8.3 to 0.1)	−11.2 (−14.6 to −7.5)* (p < 0.001)	3.3 (−4.2 to 11.4)
	Females	9740	179.6 (175.8 to 183.3)	7632	109.5 (107.0 to 111.9)	1	−5.1 (−8.8 to −1.3)* (p = 0.009)	−12.8 (−20.2 to −4.8)* (p = 0.002)	0.4 (−2.4 to 3.3)
Total		25,354	267.6 (264.1 to 271.1)	20,236	165.9 (163.5 to 168.2)		−6.0 (−10.6 to −1.1)* (p = 0.017)	−13.4 (−22.7 to −2.9)* (p = 0.013)	−0.7 (−4.3 to 3.0)

Notes: *Indicates that mean annual percentage change is significantly different from zero (p < 0.05).

Abbreviations: CI, confidence interval; No, Number of deaths.

Table 2 Trends in Age-Adjusted Rates of Avoidable Mortality Attributed to Cardiovascular Disease in Kazakhstan, 2011–2021

Disease subtype		Rate Per 100 000 (95% CI)		Average Annual Percentage Change (95% CI)*
		2011	2021	2011–2021
Chronic rheumatic heart disease	I05-I09	3.1 (2.7 to 3.5)	1.0 (0.8 to 1.1)	−11.0 (−13.2 to −8.8)* (p < 0.001)
Hypertensive diseases	I10-I15	21.0 (21.1 to 22.0)	6.6 (6.1 to 7.1)	−9.6 (−17.4 to 1.0)* (p = 0.029)
Ischaemic heart disease	I20-I25	127.8 (125.4 to 130.2)	86.7 (85.0 to 88.4)	−5.5 (−11.1 to 0.4)
Cerebrovascular diseases	I60-I69	115.7 (113.4 to 118.0)	71.6 (70.1 to 73.1)	−5.5 (−9.1 to −1.7)* (p = 0.005)

Notes: *Average annual percentage change shown for age-adjusted mortality rates for specified time range.

Figure 2 (A) Age-adjusted mortality rate from cardiovascular diseases in Kazakhstan, 2011–2021 (in female). (B) Age adjusted mortality rate from cardiovascular diseases in Kazakhstan, 2011–2021 (in male).

Figure 3 Trends in crude mortality from circulatory system disease (Chronic rheumatic heart disease (I05-I09); Hypertensive diseases (I10-I15); Ischaemic heart disease (I20-I25); Cerebrovascular diseases (I60-I69).).